Bank Of America Corp Biomarin Pharmaceutical Inc Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bank Of America Corp holds 2,789,673 shares of BMRN stock, worth $235 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,789,673

Previous 2,358,865 18.26%

Holding current value

$235 Million

Previous $227 Million 7.13%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $36.1 Million - $42.6 Million	430,808 Added 18.26%	2,789,673 $244 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $99.2 Million - $128 Million	-1,301,275 Reduced 35.55%	2,358,865 $227 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $12.5 Million - $14.5 Million	144,310 Added 4.1%	3,660,140 $317 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $208 Million - $278 Million	2,370,416 Added 206.95%	3,515,830 $342 Million
Q4 2022 Feb 10, 2023	SELL	$80.93 - $108.63 $6.32 Million - $8.48 Million	-78,091 Reduced 6.38%	1,145,414 $119 Million

Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.03 Million - $3.58 Million	36,884 Added 3.11%	1,223,505 $104 Million
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $1.42 Million - $1.73 Million	-19,926 Reduced 1.65%	1,186,621 $98.3 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $34 Million - $42.4 Million	-457,333 Reduced 27.49%	1,206,547 $93 Million
Q4 2021 Feb 08, 2022	SELL	$71.72 - $91.47 $3.26 Million - $4.16 Million	-45,515 Reduced 2.66%	1,663,880 $147 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $100,640 - $115,042	-1,346 Reduced 0.08%	1,709,395 $132 Million
Q2 2021 Sep 13, 2021	BUY	$75.51 - $84.79 $129 Million - $145 Million	1,710,741 New	1,710,741 $143 Million

Others Institutions Holding BMRN

# of Institutions

617

Shares Held

182M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Biomarin Pharmaceutical Inc Transaction History